KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
56 hedge funds and large institutions have $92.2M invested in Kinnate Biopharma Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
95% less call options, than puts
Call options by funds: $254K | Put options by funds: $5.48M
Holders
56
Holding in Top 10
2
Calls
$254K
Puts
$5.48M
Top Buyers
| 1 | +$2.77M | |
| 2 | +$1.32M | |
| 3 | +$832K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$585K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$357K |
Top Sellers
| 1 | -$5.23M | |
| 2 | -$4.32M | |
| 3 | -$792K | |
| 4 |
Two Sigma Investments
New York
|
-$710K |
| 5 |
AI
Acuitas Investments
Seattle,
Washington
|
-$687K |
